Related Experiment Video
Updated: Jul 14, 2026

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
Published on: December 26, 2012
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis
G de Laurentiis1, L Vitiello, L Racioppi
1Dept of Respiratory Medicine, AO Monaldi, Second University of Naples, Naples, Italy.
Abstract:
Pulmonary alveolar microlithiasis (PAM) is a rare diffuse lung disease characterised by the accumulation of calcium phosphate microliths within the alveoli. The causative mechanism of PAM has only recently been discovered, and involves a gene mutation of sodium phosphate co-transporter, which is expressed by alveolar epithelial cells. This mutation may have variable consequences on the clinical phenotype. However, pulmonary cell immune phenotyping in familial PAM has not previously been assessed. In the present article, the analysis of bronchoalveolar lavage fluid of two siblings with PAM diagnosis revealed a pattern of lymphocytic alveolitis with accumulation of CD8+ T-cells. The clonal complexity of this lymphocyte's population was assayed by spectratyping, which showed an oligoclonal accumulation of T-cells with a restricted variable beta T-cell receptor (TCR) gene usage. TCR analysis in peripheral blood lymphocytes revealed no abnormal patterns of T-lymphocytes. In the pulmonary alveolar microlithiasis familial cases reported, CD8-mediated maladaptive immune response may have taken place in the bronchoalveolar compartment. The relationship between this immune dysregulation and genetic background in pulmonary alveolar microlithiasis warrants further investigation.
Insights
Pulmonary alveolar microlithiasis (PAM) involves a gene mutation affecting sodium phosphate co-transporter. Familial PAM shows a CD8+ T-cell accumulation in the lungs, suggesting an immune response linked to genetics.
Area of Science:
- Pulmonary Medicine
- Immunology
- Genetics
Background:
- Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by calcium phosphate microlith accumulation.
- Recent discoveries link PAM to mutations in the sodium phosphate co-transporter gene in alveolar epithelial cells.
- The clinical impact of these genetic mutations and the associated immune response in familial PAM remain largely uncharacterized.
Observation:
- Bronchoalveolar lavage fluid analysis from two siblings with PAM revealed lymphocytic alveolitis.
- An accumulation of CD8+ T-cells was observed in the affected lung tissue.
- Spectratyping indicated an oligoclonal T-cell population with restricted T-cell receptor (TCR) gene usage.
Findings:
- Familial PAM exhibits a distinct pulmonary immune cell profile, specifically a lymphocytic alveolitis with CD8+ T-cell predominance.
- The T-cell response in the bronchoalveolar compartment appears oligoclonal, suggesting a targeted immune reaction.
- Peripheral blood T-cell populations did not show similar abnormalities, localizing the immune dysregulation to the lungs.
Implications:
- The findings suggest a CD8-mediated maladaptive immune response may contribute to the pathogenesis of familial PAM.
- This immune dysregulation, potentially linked to the genetic background, warrants further investigation in PAM.
- Understanding the interplay between genetics and immune response could lead to novel therapeutic strategies for rare lung diseases like PAM.
Related Concept Videos
Tuberculosis
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Alveoli and Alveolar Ducts
Chronic Obstructive Pulmonary Disease II: Emphysema
